David S. Boyer
机构：Retina Vitreous Associates Medical Group · ORCID：0000-0001-9219-1614
发表论文 334 篇 · 总被引 27937 次 · h-index 66
代表论文
- Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial (2024 · The Lancet · 被引 118)
- Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE (2025 · American Journal of Ophthalmology · 被引 20)
- Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients With Wet Age-Related Macular Degeneration (2024 · Ophthalmology Science · 被引 17)
- Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) (2024 · Eye · 被引 15)
- Intravitreal Aflibercept 8 mg for Diabetic Macular Edema (2025 · Ophthalmology · 被引 13)
- Reply (2024 · Retina · 被引 13)